Literature DB >> 12802668

Multimodality treatments with endoscopic mucosal resection of esophageal squamous cell carcinoma with submucosal invasion.

M Ota1, H Ide, K Hayashi, Y Murata, R Eguchi, T Nakamura, K Narumiya, I Oi, K Takasaki.   

Abstract

BACKGROUND AND STUDY AIMS: A standard treatment for esophageal squamous cell carcinoma (SCC) with submucosal invasion is considered to be radical resection at present. In this study, we evaluated the efficacy of multimodality treatments with endoscopic mucosal resection (EMR) of esophageal SCC with submucosal invasion.
METHOD: Eighteen cases of SCC with submucosal invasion were treated with EMR. Lymphatic invasion was found in 11 cases (67%), and there were no cases of blood vessel invasion. EMR was performed prior to any other treatment. Chemotherapy and/or radiotherapy were added if indicated by the histopathological features.
RESULTS: There were no cases of local recurrence. Lymph-node recurrence was detected in 1 case treated with EMR alone. There were no cases of cancer death. The overall survival rate was 83% in all patients.
CONCLUSIONS: Multimodality treatments with EMR were effective in treating esophageal SCC with submucosal invasion.

Entities:  

Mesh:

Year:  2003        PMID: 12802668     DOI: 10.1007/s00464-002-8708-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  10 in total

1.  Pre-operative chemoradiation therapy with 5-fluorouracil and low-dose daily cisplatin for esophageal cancer: a preliminary report.

Authors:  S Shimoyama; T Konishi; M Kawahara; M Kaminishi; A Ito; K Hojo; Y Takeda; H Oba; S Shimizu
Journal:  Jpn J Clin Oncol       Date:  1999-03       Impact factor: 3.019

2.  A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC)

Authors:  H Inoue; M Endo; K Takeshita; K Yoshino; Y Muraoka; H Yoneshima
Journal:  Surg Endosc       Date:  1992 Sep-Oct       Impact factor: 4.584

3.  Results of a nationwide study on the three-field lymph node dissection of esophageal cancer.

Authors:  K Isono; H Sato; K Nakayama
Journal:  Oncology       Date:  1991       Impact factor: 2.935

4.  Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan.

Authors:  M Kodama; T Kakegawa
Journal:  Surgery       Date:  1998-04       Impact factor: 3.982

5.  Endoscopic ultrasonography of the upper gastrointestinal tract.

Authors:  Y Murata; S Suzuki; H Hashimoto
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

6.  Superficial esophageal carcinoma. Surgical treatment and the results.

Authors:  H Kato; Y Tachimori; H Watanabe; H Yamaguchi; T Ishikawa; M Itabashi
Journal:  Cancer       Date:  1990-12-01       Impact factor: 6.860

7.  Problems in neoadjuvant chemoradiotherapy preceding surgery for advanced squamous cell carcinoma of the thoracic esophagus.

Authors:  K Ishida; K Koeda; N Sato; K Ikeda; K Ohtsuka; K Aoki; Y Kimura; T Iwaya; N Uesugi; R Nakamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-06

8.  Preoperative chemotherapy for esophageal cancer based on chemosensitivity testing.

Authors:  T Okuma; M Yoshioka; S Isechi; K Kondo; Y Tabira; Y Torigoe; Y Miyauchi
Journal:  J Thorac Cardiovasc Surg       Date:  1994-11       Impact factor: 5.209

9.  Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer.

Authors:  H Yamanaka; T Motohiro; T Michiura; A Asai; T Mori; K Hioki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-10

10.  Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial.

Authors:  T Iizuka; T Kakegawa; H Ide; N Ando; H Watanabe; O Tanaka; I Takagi; K Isono; K Ishida; M Arimori
Journal:  Jpn J Clin Oncol       Date:  1992-06       Impact factor: 3.019

  10 in total
  1 in total

Review 1.  Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.

Authors:  George Sgourakis; Ines Gockel; Hauke Lang
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.